Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cenovus Energy Inc T.CVE

Alternate Symbol(s):  CVE | CVE.WS | T.CVE.WT | T.CVE.PR.A | CNVEF | T.CVE.PR.B | T.CVE.PR.C | T.CVE.PR.E | T.CVE.PR.G

Cenovus Energy Inc. is a Canada-based integrated energy company. The Company has oil and natural gas production operations in Canada and the Asia Pacific region, and upgrading, refining and marketing operations in Canada and the United States. The Company's segments include Upstream, Downstream, and Corporate and Eliminations. Its Upstream segment includes Oil Sands, Conventional, and Offshore.... see more

TSX:CVE - Post Discussion

Cenovus Energy Inc > CVE Warrant
View:
Post by FairMount on Feb 05, 2021 9:45am

CVE Warrant

The warrant is trading at 4.2 now. What happens if I subscribe for the common share at an exercise price of 6.54? Does that mean I have to pay 6.54$ to buy each common share? Or I pay the difference of 6.54 minus the warrant price?  Any clarification - much appreciated!
Comment by Husky4000 on Feb 05, 2021 10:54am
The warrant gives you the right to buy CVE at 6.54.   Example: You got 1000 warrants trading at 4.20 worth 4200$ You decide to buy exercice them.  So you put 6540$ of your money.  In exchange you got 1000 CVE valued at 8100$.   If you were to sell, you would have a profit of 8100-6540=1560$. So, which one is better?  4200 in warrants or 1560 in sharevalue ...more  
Comment by RagingBull3 on Feb 05, 2021 11:21am
You could Sell your warrents for $4200 and buy CVE shares on the open market with the money.   Only difference will be the extra trading fee I think.   BUT  you hold the warrents for the LEVERAGE it offers.    Given the volatility of the common share price, I'm guessing holding the warrents (not selling yet) would be a better bet, just guessing.  But ...more  
Comment by Maxmoe on Feb 05, 2021 2:32pm
The math doesn't work. Who would pay 4.20 for a warrant plus 6.54 to exercise it? That's a total cost of 10.74 per share, for a share that trades at $8.10? Makes no sense at all.
Comment by RagingBull3 on Feb 06, 2021 9:23am
Maxmoe, You take a "hit" on the warrents now on a bet that as in my example the commons will be higher than $13.58.    You will breakeven at $10.74, and above $13.58 the gains on the warrents will outpace the commons almost 2 to 1. It depends on how you want to bet, short term, or long term?  and how soon and how high the commons will go.    I'm thinking, if ...more  
Comment by FairMount on Feb 06, 2021 2:30pm
Thank you all for replying and nice information. Does that mean if the warrant is not exercised - left expired - it has no value? I think when HSE was converted to CVE the warrant came with a value?
Comment by Husky4000 on Feb 06, 2021 2:57pm
Well, if you let it expire without either sellling it or converting it, you lose everything. The warrant did not come with a value.... The market prices it. The market thinks that the right to buy a CVE share at 6.54 within 59 months is worth 4.20 actually.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities